[OncoHost in PR Newswire] OncoHost launches PROphet® NSCLC cancer test in the United States

[OncoHost in PR Newswire] OncoHost launches PROphet® NSCLC cancer test in the United States

Source Node: 1943058

BINYAMINA, Israel, Feb. 1, 2023 /PRNewswire/ — OncoHost, a precision diagnostics company centered on predictive biomarker development for improved patient care, today announced the official launch of its PROphet® non-small lung cancer (NSCLC) Test in the United States.

Read more here.

Time Stamp:

More from OurCrowd Blog